Abe C

578 total citations
39 papers, 416 citations indexed

About

Abe C is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Abe C has authored 39 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Abe C's work include Mycobacterium research and diagnosis (11 papers), Tuberculosis Research and Epidemiology (10 papers) and Immune Response and Inflammation (5 papers). Abe C is often cited by papers focused on Mycobacterium research and diagnosis (11 papers), Tuberculosis Research and Epidemiology (10 papers) and Immune Response and Inflammation (5 papers). Abe C collaborates with scholars based in Japan, United Kingdom and Czechia. Abe C's co-authors include Yuko Kazumi, Homma Jy, Masashi Takahashi, Yutaka Fukasawa, Ken-ichi Hirano, E. Goto, Michio Kawano, Yasuhiko Suzuki, Aki Tamaru and M Makino and has published in prestigious journals such as Infection and Immunity, Journal of Applied Microbiology and Inflammation Research.

In The Last Decade

Abe C

38 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abe C Japan 10 238 211 141 82 46 39 416
Ashley M. Sherrid United States 8 260 1.1× 238 1.1× 224 1.6× 58 0.7× 46 1.0× 10 498
James M Balwit United States 5 215 0.9× 65 0.3× 195 1.4× 40 0.5× 51 1.1× 7 403
Saleena Ghanny United States 10 378 1.6× 354 1.7× 192 1.4× 81 1.0× 91 2.0× 11 606
Ellen Buschman Canada 12 164 0.7× 120 0.6× 164 1.2× 118 1.4× 89 1.9× 22 540
Yongsheng Ma United States 8 322 1.4× 96 0.5× 206 1.5× 29 0.4× 76 1.7× 10 578
A-Rum Shin South Korea 10 271 1.1× 220 1.0× 113 0.8× 61 0.7× 132 2.9× 22 417
Jacqueline Carrère France 12 414 1.7× 234 1.1× 136 1.0× 99 1.2× 45 1.0× 19 749
Rachel L. Leistikow United States 10 389 1.6× 377 1.8× 196 1.4× 90 1.1× 72 1.6× 11 622
Stacey A. Rutherford United States 12 359 1.5× 144 0.7× 244 1.7× 87 1.1× 165 3.6× 13 606
Tatsuya Akaki Japan 14 214 0.9× 296 1.4× 89 0.6× 76 0.9× 91 2.0× 22 612

Countries citing papers authored by Abe C

Since Specialization
Citations

This map shows the geographic impact of Abe C's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abe C with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abe C more than expected).

Fields of papers citing papers by Abe C

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abe C. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abe C. The network helps show where Abe C may publish in the future.

Co-authorship network of co-authors of Abe C

This figure shows the co-authorship network connecting the top 25 collaborators of Abe C. A scholar is included among the top collaborators of Abe C based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abe C. Abe C is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Jian, et al.. (2007). Evaluation of the suppressive actions of glucosamine on the interleukin-1β-mediated activation of synoviocytes. Inflammation Research. 56(10). 432–438. 32 indexed citations
2.
Nagakura, N., K. Chiba, Hiroshi Shirota, et al.. (1999). Effects of ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor, on indices of early articular lesion in MRL/MpJ-lpr/lpr mice. Inflammation Research. 48(8). 432–436. 9 indexed citations
3.
Kawada, Hiroshi, Yoichi Nakanishi, Masahiro Takahara, et al.. (1998). [Reinfection tuberculosis at a day-laborers' facility equipped with a sauna].. PubMed. 36(4). 353–7. 2 indexed citations
4.
Hirano, Ken-ichi, Masashi Takahashi, Yuko Kazumi, Yutaka Fukasawa, & Abe C. (1998). Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle and Lung Disease. 78(2). 117–122. 103 indexed citations
5.
Katsukawa, Chihiro, et al.. (1997). Characterization of the rpsL and rrs genes of streptomycin‐resistant clinical isolates of Mycobacterium tuberculosis in Japan. Journal of Applied Microbiology. 83(5). 634–640. 33 indexed citations
6.
C, Abe. (1996). Evaluation of a New Rapid Detection System for Mycobacteria Using an Oxygen Sensitive Fluorescent Sensor. Kansenshogaku zasshi. 70(4). 360–365. 4 indexed citations
7.
Hirano, Ken‐ichi, et al.. (1996). Resistance to antituberculosis drugs in Japan. Tubercle and Lung Disease. 77(2). 130–135. 18 indexed citations
8.
C, Abe, et al.. (1995). [Reproducibility of MTD system for detection of Mycobacterium tuberculosis: a cooperative study among six laboratories].. PubMed. 70(8). 467–72. 2 indexed citations
9.
C, Abe, Shin‐ichi Hirano, Toshiyasu Mase, et al.. (1995). Effects of cytogenin on spontaneous arthritis in MRL/1 mice and on pristane-induced arthritis (PIA) in DBA/1J mice.. PubMed. 17(5-6). 175–80. 4 indexed citations
10.
C, Abe, et al.. (1992). [Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria].. PubMed. 67(12). 781–6. 1 indexed citations
11.
C, Abe, Atsuko Koyama, & Takuya Nishimura. (1987). Interleukin-2 induction, response and therapy on murine lupus lesions in the MRL/l strain.. PubMed. 229. 147–56. 1 indexed citations
12.
Shiokawa, Yoshiaki, et al.. (1981). Systemic vasculitis and its renal lesions.. PubMed. 23(7). 939–46. 1 indexed citations
13.
C, Abe & Homma Jy. (1981). IgE antibody production to elastase toxoid of Pseudomonas aeruginosa in mice.. PubMed. 51(1). 71–3. 1 indexed citations
14.
C, Abe, Koichi Takeshi, Homma Jy, & Itaru Kato. (1979). Studies on the detoxification of Pseudomonas aeruginosa exotoxin.. PubMed. 32(2). 88–90. 1 indexed citations
15.
MITSUOKA, Tomotari, Yoshimi Benno, Homma Jy, & Abe C. (1978). Characterization of Propionibacterium acnes isolated from biopsy specimens obtained from patients with sarcoidosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 48(3). 275–7. 3 indexed citations
16.
Ueda, Koji, Junzo Saegusa, Kenji Fujiwara, et al.. (1978). Etiological studies on a transmissible agent from sarcoid tissues using germ-free and nude mice.. PubMed. 48(3). 269–73. 1 indexed citations
17.
Matsuoka, Masao, et al.. (1976). Susceptibility to murine leprosy bacilli of nude mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 46(3). 167–80. 6 indexed citations
18.
C, Abe, et al.. (1975). Common protective antigen (OEP) of Pseudomonas aeruginosa.. PubMed. 45(5). 355–9. 18 indexed citations
19.
Jy, Homma & Abe C. (1972). Differences in chemical nature of the endotoxins derived from dissociants, types la and sm, of Pseudomonas aeruginosa, strain N 10.. PubMed. 42(1). 23–34. 4 indexed citations
20.
Fujimori, Maiko, M Izuo, Abe C, et al.. (1964). STUDIES ON REGIONAL PERFUSION AND INTRA-ARTERIAL INFUSION FOR CANCER CHEMOTHERAPY.. PubMed. 55. 630–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026